Getting the right medicine into the hands of a patient in a timely manner has always been the ultimate goal in the clinical supply chain, as Neil Sherman, Technical Services Manager at Intelsius, remarks in this paper. As the pharmaceutical industry moves away from the ‘blockbuster era’ into biologics and personalised medicines, the challenge of maintaining a controlled supply chain, from production to the time of administering the medicine, becomes even more complex.